Generic Bevacizumab

A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.


Bevacizumab Adverse Effects [FDA Report]

Bevacizumab side effect


Synonyms
  • Avastin
  • antiVEGF

Bevacizumab Chemical

Humanized anti-VEGF antibody

Brand Names related Bevacizumab